Aligos Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
April 24, 2026 08:00 ET | Source: Aligos Therapeutics SOUTH SAN FRANCISCO,…
NYSE Content Update: UiPath Celebrates Five-Year Listing Anniversary at NYSE
NYSE issues a pre-market daily advisory direct from the trading floor.NEW YORK,…
AEON Biopharma Receives Additional Notice Related to NYSE American Continued Listing Standards
IRVINE, Calif., April 03, 2026 (GLOBE NEWSWIRE) -- AEON Biopharma, Inc. (“AEON”…
Syndax Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
April 03, 2026 16:01 ET | Source: Syndax Pharmaceuticals, Inc. NEW YORK,…
IN8bio Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
April 03, 2026 16:00 ET | Source: IN8bio, Inc NEW YORK, April…
Matinas BioPharma Receives Notice of Non-Compliance withNYSE AmericanContinued Listing Standards
BEDMINSTER, N.J., April 03, 2026 (GLOBE NEWSWIRE) -- Matinas BioPharma Holdings, Inc.…
NYSE Content Update: Koppers to Ring Closing Bell for 20th Listing Anniversary
NYSE issues a pre-market daily advisory direct from the trading floor.NEW YORK,…
Zevra Therapeutics Reports Inducement Grant to New Chief Financial Officer Under Nasdaq Listing Rule 5635(c)(4)
March 20, 2026 16:30 ET | Source: Zevra Therapeutics BOSTON, March 20,…
NYSE Content Update: United States Antimony Corp. Rings Bell to Mark its Listing
NYSE issues a pre-market daily advisory direct from the trading floor.NEW YORK,…
UroGen Pharma Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
PRINCETON, N.J., March 06, 2026 (GLOBE NEWSWIRE) -- UroGen Pharma Ltd. (Nasdaq:…
